US PRE-MARKET MOVERS: REGN, F, D, RAMP, UNH, BIO, NOW
ES -0.2% NQ -0.1% RTY -0.1%
- REGN -11.5%: Melanoma combo fails Phase 3 primary endpoint..
- F +5.5%: Plans to launch seven new vehicle models in Europe by 2029.
- D +15.0%, NEE -1.7%: NEE to acquire D in all-stock deal.
- RAMP +27.8%: Publicis agreed to buy RAMP in an all-cash $2.2B deal.
- UNH -3.8%: BRK.B exits UNH position.
- BIO +7.5%: Elliott builds BIO stake.
- NOW +5.1%: BofA reinstated coverage with a 'Buy' rating and $130 PT.
Context
In today's pre-market moves, Regeneron (REGN) is taking a significant hit after its melanoma treatment failed to meet primary endpoint criteria in a Phase 3 trial, raising concerns about its pipeline. Conversely, Ford (F) is rallying on plans to introduce seven new vehicle models in Europe by 2029, indicative of a strong recovery strategy. The acquisition of Dominion Energy (D) by NextEra Energy (NEE) is also noteworthy; it highlights consolidation trends in the utilities sector, with likely implications for regulatory scrutiny and market dynamics.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#BERKSHIRE HATHAWAY INC#REGENERON PHARMACEUTICALS INC#UNITEDHEALTH GROUP INC#SOFTWARE#SERVICENOW INC#EQUITIES#EU SESSION#US SESSION#HIGHLIGHTED#RESEARCH SHEET#MANAGED HEALTH CARE#BIOTECHNOLOGY#LIFE SCIENCES TOOLS & SERVICES#MULTI-SECTOR HOLDINGS#SYSTEMS SOFTWARE#ELECTRIC UTILITIES#HEALTH CARE PROVIDERS & SERVICES#BIOTECHNOLOGY (GROUP)#LIFE SCIENCES TOOLS & SERVICES (GROUP)#FINANCIAL SERVICES (GROUP)#ELECTRIC UTILITIES (GROUP)#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FINANCIAL SERVICES#SOFTWARE & SERVICES#UTILITIES (GROUP)#S&P 500 INDEX#NASDAQ 100 INDEX#BIO RAD LABORATORIES INC#BIO#BRK.B#EVERSOURCE ENERGY#ES#NEXTERA ENERGY INC#NEE#NOW#REGN#UNH#US PRE-MARKET#US RESEARCH#US EQUITIES